IBDEI0ZA ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16254,1,3,0)
 ;;=3^White Blood Cell Count,Elevated,Unspec
 ;;^UTILITY(U,$J,358.3,16254,1,4,0)
 ;;=4^D72.829
 ;;^UTILITY(U,$J,358.3,16254,2)
 ;;=^5002379
 ;;^UTILITY(U,$J,358.3,16255,0)
 ;;=D72.9^^88^844^37
 ;;^UTILITY(U,$J,358.3,16255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16255,1,3,0)
 ;;=3^White Blood Cells Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16255,1,4,0)
 ;;=4^D72.9
 ;;^UTILITY(U,$J,358.3,16255,2)
 ;;=^5002381
 ;;^UTILITY(U,$J,358.3,16256,0)
 ;;=L02.91^^88^845^1
 ;;^UTILITY(U,$J,358.3,16256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16256,1,3,0)
 ;;=3^Abcess,Cutaneous,Unspec
 ;;^UTILITY(U,$J,358.3,16256,1,4,0)
 ;;=4^L02.91
 ;;^UTILITY(U,$J,358.3,16256,2)
 ;;=^5009016
 ;;^UTILITY(U,$J,358.3,16257,0)
 ;;=L11.9^^88^845^2
 ;;^UTILITY(U,$J,358.3,16257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16257,1,3,0)
 ;;=3^Acantholytic Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16257,1,4,0)
 ;;=4^L11.9
 ;;^UTILITY(U,$J,358.3,16257,2)
 ;;=^5009094
 ;;^UTILITY(U,$J,358.3,16258,0)
 ;;=L83.^^88^845^3
 ;;^UTILITY(U,$J,358.3,16258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16258,1,3,0)
 ;;=3^Acanthosis Nigricans
 ;;^UTILITY(U,$J,358.3,16258,1,4,0)
 ;;=4^L83.
 ;;^UTILITY(U,$J,358.3,16258,2)
 ;;=^1451
 ;;^UTILITY(U,$J,358.3,16259,0)
 ;;=L70.9^^88^845^4
 ;;^UTILITY(U,$J,358.3,16259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16259,1,3,0)
 ;;=3^Acne,Unspec
 ;;^UTILITY(U,$J,358.3,16259,1,4,0)
 ;;=4^L70.9
 ;;^UTILITY(U,$J,358.3,16259,2)
 ;;=^5009273
 ;;^UTILITY(U,$J,358.3,16260,0)
 ;;=L57.0^^88^845^5
 ;;^UTILITY(U,$J,358.3,16260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16260,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,16260,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,16260,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,16261,0)
 ;;=N65.0^^88^845^16
 ;;^UTILITY(U,$J,358.3,16261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16261,1,3,0)
 ;;=3^Breast,Reconstructed Deformity
 ;;^UTILITY(U,$J,358.3,16261,1,4,0)
 ;;=4^N65.0
 ;;^UTILITY(U,$J,358.3,16261,2)
 ;;=^5015800
 ;;^UTILITY(U,$J,358.3,16262,0)
 ;;=N64.9^^88^845^9
 ;;^UTILITY(U,$J,358.3,16262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16262,1,3,0)
 ;;=3^Breast Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,16262,1,4,0)
 ;;=4^N64.9
 ;;^UTILITY(U,$J,358.3,16262,2)
 ;;=^5015799
 ;;^UTILITY(U,$J,358.3,16263,0)
 ;;=N65.1^^88^845^15
 ;;^UTILITY(U,$J,358.3,16263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16263,1,3,0)
 ;;=3^Breast Reconstructed Disproportion
 ;;^UTILITY(U,$J,358.3,16263,1,4,0)
 ;;=4^N65.1
 ;;^UTILITY(U,$J,358.3,16263,2)
 ;;=^5015801
 ;;^UTILITY(U,$J,358.3,16264,0)
 ;;=N60.92^^88^845^10
 ;;^UTILITY(U,$J,358.3,16264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16264,1,3,0)
 ;;=3^Breast Dysplasia,Benign Mammary,Left
 ;;^UTILITY(U,$J,358.3,16264,1,4,0)
 ;;=4^N60.92
 ;;^UTILITY(U,$J,358.3,16264,2)
 ;;=^5134091
 ;;^UTILITY(U,$J,358.3,16265,0)
 ;;=N60.91^^88^845^11
 ;;^UTILITY(U,$J,358.3,16265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16265,1,3,0)
 ;;=3^Breast Dysplasia,Benign Mammary,Right
 ;;^UTILITY(U,$J,358.3,16265,1,4,0)
 ;;=4^N60.91
 ;;^UTILITY(U,$J,358.3,16265,2)
 ;;=^5015788
 ;;^UTILITY(U,$J,358.3,16266,0)
 ;;=N62.^^88^845^12
 ;;^UTILITY(U,$J,358.3,16266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16266,1,3,0)
 ;;=3^Breast Hypertrophy
 ;;^UTILITY(U,$J,358.3,16266,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,16266,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,16267,0)
 ;;=N61.^^88^845^13
 ;;^UTILITY(U,$J,358.3,16267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16267,1,3,0)
 ;;=3^Breast Inflammatory Disorders
